In this week’s OIS Podcast, Dr. Ehsan Sadri speaks with Bob Dempsey who just assumed the CEO role for TearClear. Let’s hear how Bob’s experience taking Xiidra (Zy-dra) to market for Shire led him to the driver’s seat for one of the most promising new drug-delivery companies.
Interviewer:
Ehsan Sadri, MD
Managing Partner
Visionary MD Eye Laser institute
Interviewee:
Robert Dempsey
CEO
TearClear